Venlafaxine

Overdose Overachievers

Retrieved on: 
Wednesday, November 16, 2022
Ranolazine, Wanda, Vomiting, Database, Medicine, Pharmacy, PETS, Adderall, Dog, Amitriptyline, Dietary supplement, Knowledge, Animal, Stomach, Arrhythmia, Veterinarian, Degenerative disease, Bird, Cat, Bradycardia, Poisoning, Potassium, GiFT, Isosorbide, Patient, Veterinary medicine, Metoprolol, Hypotension, Risk, Central nervous system, Pet, CNS, Toxicology, Lethargy, Review, Diagnosis, OTC, Venlafaxine, Medical imaging, Risk management, Pharmaceutical industry, Petunia

MINNEAPOLIS, Nov. 16, 2022 /PRNewswire/ -- When your pet accidentally ingests one of your human medications, it can be of concern. The specific drug may be poisonous to non-humans, or the strength may be dangerous. What happens, however, when a pet accidentally ingests multiple medications? That's when you want the toxicology experts at Pet Poison Helpline by your side.

Key Points: 
  • MINNEAPOLIS, Nov. 16, 2022 /PRNewswire/ -- When your pet accidentally ingests one of your human medications, it can be of concern.
  • Because of its proprietary data and years of experience, the toxicology team has access to answers others simply don't.
  • "It becomes even more challenging for veterinary teams when they're treating a pet who has ingested multiple medications.
  • Not only does the veterinarian need to potentially be concerned about each specific medication, but also its potential interaction with other ingested drugs.

Greater Than 50% Reduction in Hot Flash Severity and Frequency Found with Sleepme® Cooling Sleep Systems

Retrieved on: 
Tuesday, October 4, 2022
Software, Research, Other Health, General Health, Hardware, Consumer, Technology, Retail, Science, Women, Other Technology, Health, Home Goods, ProofPilot, Menopause, Acupuncture, Anxiety, Wake Forest, Sleep, Flash, Sweatpants, Cube, CEO, Pain, Wake Forest University, Insomnia, Quality, Quality of life, Method, Social media, Woman, Pharmaceutical industry, Venlafaxine

The study revealed a greater than 50% reduction in hot flash severity and frequency during the day and night in women who used ChiliSleep Sleep Systems.

Key Points: 
  • The study revealed a greater than 50% reduction in hot flash severity and frequency during the day and night in women who used ChiliSleep Sleep Systems.
  • ChiliSleeps cooling mattress pad scored higher in reducing hot flashes than other methods such as acupuncture and Venlafaxine (a non-hormonal drug solution).
  • Hot flashes and night sweats can cause bad sleep, which can lead to women feeling tired the next day, and struggling with both concentration and motivation.
  • Under the Sleepme Inc. umbrella, the ChiliSleep brand has pioneered the award-winning Cube , OOLER , and Dock Pro Sleep Systems.

Research Report on China's Venlafaxine Markets, 2016-2020 & 2021-2025: The First Approved SNRI Inhibitor, Originally Developed by Wyeth, a Subsidiary of Pfizer, Under the Trade Name Effexor XR - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 10, 2022
Health, Pharmaceutical, Research report, Work, China Energy Research Report, FDA, Urbanization, Wyeth, Dosage form, Depression, Venlafaxine, Patient, COVID-19, SNRI, Growth, CAGR, Animal, Pharmaceutical industry, Pfizer

The "Research Report on China's Venlafaxine Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Report on China's Venlafaxine Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • It was originally developed by Wyeth, a subsidiary of Pfizer, under the trade name Effexor XR.
  • China's venlafaxine market is expected to see growth from 2021 to 2025 as COVID-19 is under control in China.
  • Prospects of China's Venlafaxine Market, 2021-2025
    2 Sales of Venlafaxine in China, 2016-2020
    2.3 Sales of Venlafaxine in China by Dosage Form, 2016-2020

BioXcel Therapeutics Announces Primary and Secondary Endpoints Met in Two Pivotal Phase 3 Trials of BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder

Retrieved on: 
Monday, July 20, 2020
Psychiatry, Mood disorders, Abnormal psychology, Psychiatric diagnosis, Bipolar disorder, Depression, RTT, Comparison of bipolar disorder and schizophrenia, Venlafaxine

At 20 minutes, both doses were statistically significant in patients with bipolar disorder (p

Key Points: 
  • At 20 minutes, both doses were statistically significant in patients with bipolar disorder (p
  • The PEC total score is a validated regulatory endpoint for measuring acute agitation in schizophrenia and bipolar patients.
  • BXCL501 is an investigational proprietary sublingual thin film of dexmedetomidine, a selective alpha-2a receptor agonist for the treatment of acute agitation.
  • BXCL501 has been granted Fast Track Designation by the U.S. Food and Drug Administration for the acute treatment of agitation.